Autoreactive CD4+ T cells, such as T helper (Th)1 and Th17 subtypes, have been found to involve in the pathogenesis of several autoimmune disorders, including multiple sclerosis (MS), inflammatory bowel disease (IBD) and rheumatoid arthritis (RA). This evidence concerns the gene CD4 and myeloid sarcoma.